NMT Medical, Inc. (NASDAQ: NMTI), a leader in the emerging field of structural heart repair, is focused on designing, developing, manufacturing and marketing proprietary implant technologies that allow interventional cardiologists to treat certain structural heart disease through minimally invasive, catheter-based procedures. By working with qualified physicians, the company has provided minimally invasive treatment for an array of cardiac defects for more than two decades. For further information, visit the Company’s web site at www.nmtmedical.com.
- 18 years ago
QualityStocks
NMT Medical, Inc. (NASDAQ: NMTI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones
Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform
WRAP offerings illustrate a broader industry trend toward building connected ecosystems rather than standalone products.…
-
Brownfield Gold Projects Could Hold an Edge in Today’s Permitting Environment
Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.…